The role of complementary lymphadenectomy in patients with incidental endometrial cancer
No clear therapeutic or prognostic role was identified for complementary lymphadenectomy during a second surgery in patients with endometrial cancer. Although adjuvant therapy was more common in patients who underwent complementary lymphadenectomy, it was not independently associated with receiving adjuvant therapy. Individualizing treatment decisions remains important when considering a second surgical procedure.
Authors
- David Cantú-de-León
- Carlos Pérez‐Plasencia (ORCID: https://orcid.org/0000-0002-8593-8211)
- Cintia María Sepúlveda-Rivera
- Salim Barquet-Muñoz (ORCID: https://orcid.org/0000-0002-3950-157X)
- Delia Pérez‐Montiel (ORCID: https://orcid.org/0000-0002-9338-2284)
- Diddier Prada (ORCID: https://orcid.org/0000-0002-6517-156X)
- Alejandro Mohar (ORCID: https://orcid.org/0000-0002-4730-4787)
- Jonathan González-Ruíz (ORCID: https://orcid.org/0000-0003-4323-4061)
- Andrea Ramírez
- Pamela Martínez-Alpizar
- Pamela Rico-Mejía
Institutions
- Mount Sinai Health System (US)
- Instituto Nacional de Perinatología (MX)
- National Institute of Genomic Medicine (MX)
- Instituto Nacional de Cancerología (MX)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-10-22
- DOI
- https://doi.org/10.3389/fonc.2025.1635672
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00